|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The negative
meson beam has a number of favorable characteristics which,
taken collectively, make a high-output
beam attractive for radiotherapy. These
include: (1) a depth-dose and dose equivalent (dose x RBE) pattern superior to those
now available; (2) a relatively low OER in
the peak portion of the depth-dose curve;
and (3) less repair of sublethal cell damage
in the peak portion.
The unique, and readily-tailored superior
depth-dose patterns obtainable with negative
mesons would provide a distinct
advantage in radiotherapy. The clinical
gain to be expected from such sharply
localized radiation is difficult to assess
quantitatively from presently available
data, and it is not possible to predict
whether the over-all improvement in morbidity and mortality is likely to be 5 per
cent, 10 per cent, or more.
The favorable OER is advantageous.
This does not in itself constitute a compelling reason for making available a high
intensity source of negative
mesons,
since other currently available sources of
high LET radiation, namely fast neutrons,
are likely to be suitable for the evaluation
of the importance of hypoxic tumor cells
in radiotherapy and the degree to which
high LET radiations may help to overcome
this problem. The densely ionizing peak
portion of the
- meson depth-dose curve
can be confined nearly selectively to the
tumor volume. The resultant lower fraction
of repairable damage in tumor versus most
irradiated normal cells will result in favorable therapeutic ratios which become more
favorable with lowered dose rate of fractionation.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |